C. S. T. Pharma Limited

Walsall, United Kingdom

Classification

Private

About

About

C. S. T. Pharma Limited is a privately-held company that operates in the pharmaceutical distribution industry. C. S. T. Pharma Limited headquarters are located in Walsall, United Kingdom. C. S. T. Pharma Limited was founded in 2001. Developments & Risks The company increased gross profit margin from 4.3% to 5.7% from 2014 to 2015, and revenue increased 34.1% over the previous year. CST Pharma expects to maintain its import and export operations in the coming year while diversifying its product range in the pharmaceutical industry. The company sites exchange rate variances as a major risk, and plans to mitigate it by purchasing required currencies at favorable exchange rates through forward currency contracts and other financial products. Interest risks are another potential risk, which are at historic lows in the UK, and a rise in rates would lead to increased costs.

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

Keywords

Keywords

Classified

Private